A. Molins

2.5k total citations
49 papers, 1.6k citations indexed

About

A. Molins is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Neurology. According to data from OpenAlex, A. Molins has authored 49 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Psychiatry and Mental health, 20 papers in Pediatrics, Perinatology and Child Health and 15 papers in Neurology. Recurrent topics in A. Molins's work include Epilepsy research and treatment (18 papers), Pharmacological Effects and Toxicity Studies (17 papers) and Neuroscience and Neuropharmacology Research (8 papers). A. Molins is often cited by papers focused on Epilepsy research and treatment (18 papers), Pharmacological Effects and Toxicity Studies (17 papers) and Neuroscience and Neuropharmacology Research (8 papers). A. Molins collaborates with scholars based in Spain, United States and Mexico. A. Molins's co-authors include Antoni Dávalos, Ferrán Gónzalez‐Huix, David Genı́s, Rosa Suñer Soler, Jaume Marrugat, Silvia Soler, D. E. Genis, Joaquı́n Serena, Tomás Segura and Vicente Villanueva and has published in prestigious journals such as Stroke, Biological Psychiatry and Acta Neuropathologica.

In The Last Decade

A. Molins

48 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Molins Spain 21 538 494 366 358 330 49 1.6k
Carmel Armon United States 27 1.6k 3.0× 360 0.7× 432 1.2× 215 0.6× 268 0.8× 77 2.7k
E. Bottacchi Italy 21 902 1.7× 160 0.3× 233 0.6× 69 0.2× 156 0.5× 49 1.5k
Aïcha Soumaré France 20 568 1.1× 243 0.5× 462 1.3× 181 0.5× 139 0.4× 31 1.4k
J D Wallace United States 15 811 1.5× 251 0.5× 433 1.2× 185 0.5× 163 0.5× 17 1.4k
Amer Alshekhlee United States 27 924 1.7× 170 0.3× 257 0.7× 58 0.2× 245 0.7× 62 2.1k
Massimiliano Prencipe Italy 28 685 1.3× 739 1.5× 190 0.5× 173 0.5× 368 1.1× 71 2.3k
Cecil O. Borel United States 29 1.1k 2.0× 105 0.2× 196 0.5× 79 0.2× 316 1.0× 82 2.3k
Hans Katzberg Canada 27 1.5k 2.8× 90 0.2× 349 1.0× 66 0.2× 161 0.5× 124 2.4k
Masaki Kurihara Japan 24 138 0.3× 100 0.2× 338 0.9× 70 0.2× 176 0.5× 80 1.8k
Benjamin F.J. Verhaaren Netherlands 17 301 0.6× 392 0.8× 84 0.2× 64 0.2× 368 1.1× 31 1.5k

Countries citing papers authored by A. Molins

Since Specialization
Citations

This map shows the geographic impact of A. Molins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Molins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Molins more than expected).

Fields of papers citing papers by A. Molins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Molins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Molins. The network helps show where A. Molins may publish in the future.

Co-authorship network of co-authors of A. Molins

This figure shows the co-authorship network connecting the top 25 collaborators of A. Molins. A scholar is included among the top collaborators of A. Molins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Molins. A. Molins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Montoya, Javier, Mercè Falip, Javier Aparicio, et al.. (2018). Retrospective study of perampanel efficacy and tolerability in myoclonic seizures. Acta Neurologica Scandinavica. 138(2). 122–129. 21 indexed citations
2.
Rocamora, Rodrigo, Miguel Ley, A. Molins, et al.. (2017). Effect of lacosamide on depression and anxiety symptoms in patients with focal refractory epilepsy: A prospective multicenter study. Epilepsy & Behavior. 79. 87–92. 25 indexed citations
3.
Heras, M., Juan Luís Becerra, Desirée Muriana, et al.. (2015). EEG extreme delta brush: An ictal pattern in patients with anti-NMDA receptor encephalitis. Epilepsy & Behavior. 49. 280–285. 62 indexed citations
4.
Villanueva, Vicente, Mercedes Garcés, José M. Serratosa, et al.. (2014). Early Add-on Lacosamide in a Real-Life Setting: Results of the REALLY Study. Clinical Drug Investigation. 35(2). 121–131. 30 indexed citations
5.
Rocamora, Rodrigo, et al.. (2014). Pilomotor seizures: An autonomic semiology of limbic encephalitis?. Seizure. 23(8). 670–673. 70 indexed citations
6.
Villanueva, Vicente, Francisco J. López, José M. Serratosa, et al.. (2013). Control of seizures in different stages of partial epilepsy: LACO-EXP, a Spanish retrospective study of lacosamide. Epilepsy & Behavior. 29(2). 349–356. 37 indexed citations
7.
Falip, Mercè, Mar Carreño, Júlia Miró, et al.. (2012). Prevalence and immunological spectrum of temporal lobe epilepsy with glutamic acid decarboxylase antibodies. European Journal of Neurology. 19(6). 827–833. 81 indexed citations
8.
Falip, Mercè, Vicente Villanueva, Pilar de la Peña, et al.. (2010). Efficacy of intravenous levetiracetam as an add-on treatment in status epilepticus: A multicentric observational study. Seizure. 20(1). 60–64. 33 indexed citations
9.
Matías‐Guiu, Jorge, et al.. (2010). Acceptability and tolerability of levetiracetam oral solution forthe treatment of partial-onset seizures: the SOLUCIÓN study. Methods and Findings in Experimental and Clinical Pharmacology. 32(7). 507–507. 1 indexed citations
10.
Martínez‐Fernández, Raúl, Antoni Gelabert, M.J. Pablo, Olga Carmona, & A. Molins. (2009). Status epilepticus with visual seizures in ketotic hyperglycemia. Epilepsy & Behavior. 16(4). 660–662. 7 indexed citations
11.
Kanner, Andrés M., et al.. (2008). Risks and Benefits of Generic Antiepileptic Drugs. The Neurologist. 14(6). S66–S72. 7 indexed citations
12.
Peñas, Juan José García, et al.. (2007). Status Epilepticus. The Neurologist. 13(6). S62–S73. 11 indexed citations
13.
Carreño, Mar, Iratxe Maestro, A. Molins, et al.. (2007). Pregabalin as add-on therapy for refractory partial seizures in every day clinical practice. Seizure. 16(8). 709–712. 19 indexed citations
14.
Genis, D. E., Antonio Dávalos, A. Molins, & Isidró Ferrer. (1997). Wolfram syndrome: a neuropathological study. Acta Neuropathologica. 93(4). 426–429. 43 indexed citations
15.
Catalán, Roberto, et al.. (1994). Neuropeptide Y cerebrospinal fluid levels in patients with normal pressure hydrocephalus syndrome. Biological Psychiatry. 36(1). 61–63. 15 indexed citations
16.
Dávalos, A., et al.. (1992). Epileptic Seizures at the Onset of Stroke. Cerebrovascular Diseases. 2(6). 327–331. 44 indexed citations
17.
Sahuquillo, Juan, et al.. (1991). Reappraisal of the intracranial pressure and cerebrospinal fluid dynamics in patients with the so-called ?Normal pressure hydrocephalus? syndrome. Acta Neurochirurgica. 112(1-2). 50–61. 100 indexed citations
18.
Molins, A., et al.. (1990). [Hypopotassemic myopathy caused by topical administration of 9 alpha fluoroprednisolone].. PubMed. 2(5). 244–6. 1 indexed citations
19.
Catalán, Rosa, et al.. (1989). C18 cartridge extraction method to measure calcitonin in human cerebrospinal fluid. Clinica Chimica Acta. 182(3). 309–312. 4 indexed citations
20.
Titus, F, et al.. (1989). Migraine-related stroke: brain infarction in superior cerebellar artery territory demonstrated by nuclear magnetic resonance. Acta Neurologica Scandinavica. 79(5). 357–360. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carmel Armon Breakdown of academic impact, for papers by E. Bottacchi Breakdown of academic impact, for papers by Aïcha Soumaré Breakdown of academic impact, for papers by J D Wallace Breakdown of academic impact, for papers by Amer Alshekhlee Breakdown of academic impact, for papers by Massimiliano Prencipe Breakdown of academic impact, for papers by Cecil O. Borel Breakdown of academic impact, for papers by Hans Katzberg Breakdown of academic impact, for papers by Masaki Kurihara Breakdown of academic impact, for papers by Benjamin F.J. Verhaaren
Rankless by CCL
2026